Do analysts rate RKDA or NCRA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Nocera 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is RKDA or NCRA more profitable?

Nocera has a net margin of -44.02% compared to Arcadia Biosciences' net margin of -195.94%. Arcadia Biosciences' return on equity of -113.73% beat Nocera's return on equity. Company Net Margins Return on Equity Return on Assets Arcadia Biosciences -195.94% -113.73% -68.47% Nocera -44.02% -207.32% -47.66%

Do analysts rate CEAD or RKDA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CEA Industries 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer IVP or RKDA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspire Veterinary Partners 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer RKDA or ORIS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Oriental Rise 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, RKDA or ORIS?

Oriental Rise has higher revenue and earnings than Arcadia Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Arcadia Biosciences $4.86M 0.30 -$2.34M -$5.73 N/A Oriental Rise $12.22M 0.04 $680K N/A N/A

Do analysts recommend EDBL or RKDA?

Edible Garden currently has a consensus price target of $45.00, indicating a potential upside of 1,873.68%. Given Edible Garden's stronger consensus rating and higher possible upside, research analysts plainly believe Edible Garden is more favorable than Arcadia Biosciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edible Garden 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Arcadia Biosciences (RKDA) Competitors

$0.66 +0.03 (+5.55%)

As of 04:00 PM Eastern

Compare

RKDA vs. NCRA, CEAD, IVP, ORIS, and EDBL

Should you buy Arcadia Biosciences stock or one of its competitors? MarketBeat compares Arcadia Biosciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Arcadia Biosciences include Nocera (NCRA), CEA Industries (CEAD), Inspire Veterinary Partners (IVP), Oriental Rise (ORIS), and Edible Garden (EDBL).

How does Arcadia Biosciences compare to Nocera?

Arcadia Biosciences (NASDAQ:RKDA) and Nocera (NASDAQ:NCRA) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, dividends and earnings.

Arcadia Biosciences has higher earnings, but lower revenue than Nocera. Nocera is trading at a lower price-to-earnings ratio than Arcadia Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arcadia Biosciences	$4.86M	0.30	-$2.34M	-$5.73	N/A
Nocera	$11.37M	0.24	-$2.84M	-$6.60	N/A

17.7% of Arcadia Biosciences shares are held by institutional investors. Comparatively, 1.3% of Nocera shares are held by institutional investors. 8.2% of Arcadia Biosciences shares are held by company insiders. Comparatively, 5.2% of Nocera shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Nocera	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Nocera had 5 more articles in the media than Arcadia Biosciences. MarketBeat recorded 5 mentions for Nocera and 0 mentions for Arcadia Biosciences. Arcadia Biosciences' average media sentiment score of 0.98 beat Nocera's score of 0.37 indicating that Arcadia Biosciences is being referred to more favorably in the media.

Company	Overall Sentiment
Arcadia Biosciences	Positive
Nocera	Neutral

Arcadia Biosciences has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market. Comparatively, Nocera has a beta of 1.89, suggesting that its share price is 89% more volatile than the broader market.

Nocera has a net margin of -44.02% compared to Arcadia Biosciences' net margin of -195.94%. Arcadia Biosciences' return on equity of -113.73% beat Nocera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Arcadia Biosciences	-195.94%	-113.73%	-68.47%
Nocera	-44.02%	-207.32%	-47.66%

Summary

Arcadia Biosciences beats Nocera on 8 of the 13 factors compared between the two stocks.

How does Arcadia Biosciences compare to CEA Industries?

CEA Industries (NASDAQ:CEAD) and Arcadia Biosciences (NASDAQ:RKDA) are related small-cap companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

Arcadia Biosciences has higher revenue and earnings than CEA Industries. CEA Industries is trading at a lower price-to-earnings ratio than Arcadia Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CEA Industries	$3.28M	0.65	-$2.91M	-$4.23	N/A
Arcadia Biosciences	$4.86M	0.30	-$2.34M	-$5.73	N/A

CEA Industries has a beta of 0.54, indicating that its share price is 46% less volatile than the broader market. Comparatively, Arcadia Biosciences has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market.

In the previous week, Arcadia Biosciences' average media sentiment score of 0.98 beat CEA Industries' score of 0.00 indicating that Arcadia Biosciences is being referred to more favorably in the news media.

Company	Overall Sentiment
CEA Industries	Neutral
Arcadia Biosciences	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CEA Industries	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

21.6% of CEA Industries shares are owned by institutional investors. Comparatively, 17.7% of Arcadia Biosciences shares are owned by institutional investors. 4.8% of CEA Industries shares are owned by company insiders. Comparatively, 8.2% of Arcadia Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

CEA Industries has a net margin of -118.08% compared to Arcadia Biosciences' net margin of -195.94%. CEA Industries' return on equity of -27.79% beat Arcadia Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CEA Industries	-118.08%	-27.79%	-24.75%
Arcadia Biosciences	-195.94%	-113.73%	-68.47%

Summary

Arcadia Biosciences beats CEA Industries on 7 of the 13 factors compared between the two stocks.

How does Arcadia Biosciences compare to Inspire Veterinary Partners?

Inspire Veterinary Partners (NASDAQ:IVP) and Arcadia Biosciences (NASDAQ:RKDA) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.

4.8% of Inspire Veterinary Partners shares are held by institutional investors. Comparatively, 17.7% of Arcadia Biosciences shares are held by institutional investors. 6.4% of Inspire Veterinary Partners shares are held by insiders. Comparatively, 8.2% of Arcadia Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Arcadia Biosciences has lower revenue, but higher earnings than Inspire Veterinary Partners. Arcadia Biosciences is trading at a lower price-to-earnings ratio than Inspire Veterinary Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Veterinary Partners	$15.56M	0.09	-$14.26M	-$2.20	N/A
Arcadia Biosciences	$4.86M	0.30	-$2.34M	-$5.73	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Veterinary Partners	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Inspire Veterinary Partners has a net margin of -76.75% compared to Arcadia Biosciences' net margin of -195.94%. Arcadia Biosciences' return on equity of -113.73% beat Inspire Veterinary Partners' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspire Veterinary Partners	-76.75%	-520.34%	-55.79%
Arcadia Biosciences	-195.94%	-113.73%	-68.47%

In the previous week, Arcadia Biosciences' average media sentiment score of 0.98 beat Inspire Veterinary Partners' score of 0.00 indicating that Arcadia Biosciences is being referred to more favorably in the news media.

Company	Overall Sentiment
Inspire Veterinary Partners	Neutral
Arcadia Biosciences	Positive

Inspire Veterinary Partners has a beta of -0.49, meaning that its stock price is 149% less volatile than the broader market. Comparatively, Arcadia Biosciences has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market.

Summary

Arcadia Biosciences beats Inspire Veterinary Partners on 7 of the 12 factors compared between the two stocks.

How does Arcadia Biosciences compare to Oriental Rise?

Arcadia Biosciences (NASDAQ:RKDA) and Oriental Rise (NASDAQ:ORIS) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.

17.7% of Arcadia Biosciences shares are owned by institutional investors. 8.2% of Arcadia Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Oriental Rise has higher revenue and earnings than Arcadia Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arcadia Biosciences	$4.86M	0.30	-$2.34M	-$5.73	N/A
Oriental Rise	$12.22M	0.04	$680K	N/A	N/A

In the previous week, Arcadia Biosciences' average media sentiment score of 0.98 beat Oriental Rise's score of 0.00 indicating that Arcadia Biosciences is being referred to more favorably in the media.

Company	Overall Sentiment
Arcadia Biosciences	Positive
Oriental Rise	Neutral

Oriental Rise has a net margin of 0.00% compared to Arcadia Biosciences' net margin of -195.94%. Oriental Rise's return on equity of 0.00% beat Arcadia Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Arcadia Biosciences	-195.94%	-113.73%	-68.47%
Oriental Rise	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Oriental Rise	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Arcadia Biosciences has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market. Comparatively, Oriental Rise has a beta of 1.54, suggesting that its stock price is 54% more volatile than the broader market.

Summary

Oriental Rise beats Arcadia Biosciences on 6 of the 10 factors compared between the two stocks.

How does Arcadia Biosciences compare to Edible Garden?

Edible Garden (NASDAQ:EDBL) and Arcadia Biosciences (NASDAQ:RKDA) are both small-cap consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment and valuation.

In the previous week, Edible Garden had 2 more articles in the media than Arcadia Biosciences. MarketBeat recorded 2 mentions for Edible Garden and 0 mentions for Arcadia Biosciences. Arcadia Biosciences' average media sentiment score of 0.98 beat Edible Garden's score of 0.60 indicating that Arcadia Biosciences is being referred to more favorably in the news media.

Company	Overall Sentiment
Edible Garden	Positive
Arcadia Biosciences	Positive

Edible Garden currently has a consensus price target of $45.00, indicating a potential upside of 1,873.68%. Given Edible Garden's stronger consensus rating and higher possible upside, research analysts plainly believe Edible Garden is more favorable than Arcadia Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edible Garden	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

13.0% of Edible Garden shares are held by institutional investors. Comparatively, 17.7% of Arcadia Biosciences shares are held by institutional investors. 0.8% of Edible Garden shares are held by company insiders. Comparatively, 8.2% of Arcadia Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Edible Garden has a beta of 1.78, suggesting that its stock price is 78% more volatile than the broader market. Comparatively, Arcadia Biosciences has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market.

Edible Garden has a net margin of -131.59% compared to Arcadia Biosciences' net margin of -195.94%. Edible Garden's return on equity of 0.00% beat Arcadia Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edible Garden	-131.59%	N/A	-88.36%
Arcadia Biosciences	-195.94%	-113.73%	-68.47%

Arcadia Biosciences has lower revenue, but higher earnings than Edible Garden. Arcadia Biosciences is trading at a lower price-to-earnings ratio than Edible Garden, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edible Garden	$12.81M	0.02	-$17.33M	-$4.94 thousand	N/A
Arcadia Biosciences	$4.86M	0.30	-$2.34M	-$5.73	N/A

Summary

Edible Garden beats Arcadia Biosciences on 9 of the 16 factors compared between the two stocks.

Get Arcadia Biosciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RKDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RKDA vs. The Competition

Export

Metric	Arcadia Biosciences	Beverages Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$1.36M	$23.14B	$16.21B	$12.45B
Dividend Yield	N/A	2.64%	3.20%	10.03%
P/E Ratio	-0.12	15.64	13.64	22.69
Price / Sales	0.30	29.78	262,279.52	92.16
Price / Cash	0.48	18.00	56.11	34.82
Price / Book	0.28	4.01	4.99	6.21
Net Income	-$2.34M	$920.79M	$841.31M	$347.49M
7 Day Performance	3.27%	1.26%	0.94%	0.89%
1 Month Performance	-10.00%	-1.07%	-0.64%	-3.60%
1 Year Performance	-84.27%	-4.53%	13.00%	20.46%

Arcadia Biosciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RKDA Arcadia Biosciences	1.1814 of 5 stars	$0.66 +5.6%	N/A	-85.1%	$1.36M	$4.86M	N/A	60	Positive News Gap Up
NCRA Nocera	0.9679 of 5 stars	$3.03 +111.8%	N/A	-95.9%	$4.70M	$13.63M	N/A	10	Gap Up High Trading Volume
CEAD CEA Industries	N/A	$2.77 -2.8%	N/A	-87.5%	$2.22M	$3.28M	N/A	30	Gap Up High Trading Volume
IVP Inspire Veterinary Partners	0.0475 of 5 stars	$0.03 flat	N/A	N/A	$1.41M	$15.56M	N/A	156
ORIS Oriental Rise	N/A	$1.83 flat	N/A	N/A	$503K	$12.22M	N/A	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RKDA) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Arcadia Biosciences (RKDA) Competitors

RKDA vs. NCRA, CEAD, IVP, ORIS, and EDBL

How does Arcadia Biosciences compare to Nocera?

Summary

How does Arcadia Biosciences compare to CEA Industries?

Summary

How does Arcadia Biosciences compare to Inspire Veterinary Partners?

Summary

How does Arcadia Biosciences compare to Oriental Rise?

Summary

How does Arcadia Biosciences compare to Edible Garden?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RKDA vs. The Competition

Arcadia Biosciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Arcadia Biosciences (RKDA) Competitors

RKDA vs. NCRA, CEAD, IVP, ORIS, and EDBL

How does Arcadia Biosciences compare to Nocera?

Which has better valuation & earnings, RKDA or NCRA?

Do institutionals & insiders hold more shares of RKDA or NCRA?

Do analysts rate RKDA or NCRA?

Does the media prefer RKDA or NCRA?

Which has more volatility and risk, RKDA or NCRA?

Is RKDA or NCRA more profitable?

Summary

How does Arcadia Biosciences compare to CEA Industries?

Which has preferable valuation and earnings, CEAD or RKDA?

Which has more risk and volatility, CEAD or RKDA?

Does the media favor CEAD or RKDA?

Do analysts rate CEAD or RKDA?

Do insiders and institutionals have more ownership in CEAD or RKDA?

Is CEAD or RKDA more profitable?

Summary

How does Arcadia Biosciences compare to Inspire Veterinary Partners?

Do institutionals & insiders believe in IVP or RKDA?

Which has higher earnings & valuation, IVP or RKDA?

Do analysts prefer IVP or RKDA?

Is IVP or RKDA more profitable?

Does the media favor IVP or RKDA?

Which has more volatility & risk, IVP or RKDA?

Summary

How does Arcadia Biosciences compare to Oriental Rise?

Do institutionals and insiders have more ownership in RKDA or ORIS?

Which has higher valuation & earnings, RKDA or ORIS?

Does the media favor RKDA or ORIS?

Is RKDA or ORIS more profitable?

Do analysts prefer RKDA or ORIS?

Which has more risk & volatility, RKDA or ORIS?

Summary

How does Arcadia Biosciences compare to Edible Garden?

Does the media prefer EDBL or RKDA?

Do analysts recommend EDBL or RKDA?

Do insiders and institutionals hold more shares of EDBL or RKDA?

Which has more risk and volatility, EDBL or RKDA?

Is EDBL or RKDA more profitable?

Which has preferable valuation & earnings, EDBL or RKDA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RKDA vs. The Competition

Arcadia Biosciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools